Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Healthy Volunteers)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06478420
What this trial is testing

COVID-19 Omicron BA.5 Subvariant Dose Finding Infection Study

Who this might be right for
SARS-CoV-2 Infection
University of Oxford 45
Not applicableStudy completedNCT05311865
What this trial is testing

Transmission of Covid-19 During Clubbing Events in Closed Places

Who this might be right for
Healthy Participant
ANRS, Emerging Infectious Diseases 1,216
Testing effectiveness (Phase 2)Ended earlyNCT04498247
What this trial is testing

Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)

Who this might be right for
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC 263
Large-scale testing (Phase 3)UnknownNCT05522335
What this trial is testing

Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers

Who this might be right for
COVID-19 Respiratory Infection
Bharat Biotech International Limited 3,160
Testing effectiveness (Phase 2)Study completedNCT04537208
What this trial is testing

Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older

Who this might be right for
COVID-19 (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 441
Early research (Phase 1)Study completedNCT05677893
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

Who this might be right for
Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
Oneness Biotech Co., Ltd. 44
Early research (Phase 1)Study completedNCT04632706
What this trial is testing

Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19

Who this might be right for
Covid19
MedinCell S.A 24
Early research (Phase 1)Study completedNCT05364840
What this trial is testing

Study to Assess the Safety, Tolerability and Pharmacokinetics of STI-1558 in Healthy Volunteers

Who this might be right for
COVID-19
Sorrento Therapeutics, Inc. 58
Early research (Phase 1)Study completedNCT05246878
What this trial is testing

EDP-235 in Healthy Subjects

Who this might be right for
SARS CoV 2 Infection
Enanta Pharmaceuticals, Inc 72
Early research (Phase 1)Study completedNCT04497298
What this trial is testing

Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine

Who this might be right for
COVID-19
Institut Pasteur 90
Early research (Phase 1)Study completedNCT04405908
What this trial is testing

SCB-2019 as COVID-19 Vaccine

Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty 166
Early research (Phase 1)WithdrawnNCT06397144
What this trial is testing

A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants

Who this might be right for
Biological AvailabilityHealthy Participants
Pfizer
Early research (Phase 1)Study completedNCT06945276
What this trial is testing

Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy Volunteers

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 51
Early research (Phase 1)Looking for participantsNCT07093580
What this trial is testing

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

Who this might be right for
Healthy Participants
Shionogi 98
Early research (Phase 1)UnknownNCT05182567
What this trial is testing

GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19)

Who this might be right for
COVID-19Healthy
GeneOne Life Science, Inc. 69
Testing effectiveness (Phase 2)Study completedNCT04471519
What this trial is testing

Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers

Who this might be right for
COVID-19SARS-CoV-2 Infection
Bharat Biotech International Limited 755
Early research (Phase 1)Study completedNCT05129475
What this trial is testing

Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult Participants

Who this might be right for
Healthy Participants
Pfizer 12
Early research (Phase 1)Study completedNCT05685719
What this trial is testing

Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558

Who this might be right for
COVID-19 Pneumonia
Zhejiang ACEA Pharmaceutical Co. Ltd. 37
Early research (Phase 1)Active Not RecruitingNCT06950177
What this trial is testing

Pancoronavirus Vaccine Study in Healthy Adults

Who this might be right for
COVID-19 Respiratory InfectionSARS CoV 2 InfectionCOVID-19 Vaccine
Duke University 51
Early research (Phase 1)Study completedNCT05523739
What this trial is testing

Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients

Who this might be right for
SARS-CoV-2 Infection
Zhejiang ACEA Pharmaceutical Co. Ltd. 79
Next Page